Akums subsidiary to acquire Oriflame India manufacturing business for Rs 56 Cr
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs' wholly-owned subsidiary Pure and Cure Healthcare will acquire Oriflame India's manufacturing business for Rs 56 Crore in cash. The deal includes two plants in Roorkee (Uttarakhand) and Noida (UP), plus a Noida warehouse. Trademark and marketing rights are excluded. The move marks Akums' entry into color cosmetics and expands its skincare and wellness capabilities. Expected to close by August 31, 2026. No related party issues or regulatory approvals needed.
Expands manufacturing capacity and enters color cosmetics segment. Modest deal size at Rs 56 Cr suggests limited near-term earnings impact, but opens a new growth avenue.